PERFORMANT HEALTHCARE INC (PFMT) Fundamental Analysis & Valuation

NASDAQ:PFMT • US71377E1055

Current stock price

3.56 USD
-0.12 (-3.26%)
At close:
3.56 USD
0 (0%)
After Hours:

This PFMT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PFMT Profitability Analysis

1.1 Basic Checks

  • In the past year PFMT has reported negative net income.
  • PFMT had a positive operating cash flow in the past year.
  • PFMT had negative earnings in each of the past 5 years.
  • In multiple years PFMT reported negative operating cash flow during the last 5 years.
PFMT Yearly Net Income VS EBIT VS OCF VS FCFPFMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -7.99%, PFMT is doing worse than 67.29% of the companies in the same industry.
  • PFMT has a Return On Equity of -10.82%. This is comparable to the rest of the industry: PFMT outperforms 42.06% of its industry peers.
Industry RankSector Rank
ROA -7.99%
ROE -10.82%
ROIC N/A
ROA(3y)-7.17%
ROA(5y)-10.38%
ROE(3y)-9.84%
ROE(5y)-22.57%
ROIC(3y)N/A
ROIC(5y)N/A
PFMT Yearly ROA, ROE, ROICPFMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PFMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PFMT Yearly Profit, Operating, Gross MarginsPFMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. PFMT Health Analysis

2.1 Basic Checks

  • PFMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PFMT has more shares outstanding
  • PFMT has a better debt/assets ratio than last year.
PFMT Yearly Shares OutstandingPFMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
PFMT Yearly Total Debt VS Total AssetsPFMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 6.53 indicates that PFMT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 6.53, PFMT belongs to the best of the industry, outperforming 89.72% of the companies in the same industry.
  • PFMT has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.11, PFMT is in the better half of the industry, outperforming 72.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 6.53
ROIC/WACCN/A
WACC9.19%
PFMT Yearly LT Debt VS Equity VS FCFPFMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 2.67 indicates that PFMT has no problem at all paying its short term obligations.
  • PFMT's Current ratio of 2.67 is amongst the best of the industry. PFMT outperforms 85.05% of its industry peers.
  • A Quick Ratio of 2.67 indicates that PFMT has no problem at all paying its short term obligations.
  • PFMT has a better Quick ratio (2.67) than 85.05% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.67
PFMT Yearly Current Assets VS Current LiabilitesPFMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PFMT Growth Analysis

3.1 Past

  • PFMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
  • The Revenue has grown by 9.38% in the past year. This is quite good.
  • Measured over the past years, PFMT shows a decrease in Revenue. The Revenue has been decreasing by -6.09% on average per year.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y-9.98%
Revenue growth 5Y-6.09%
Sales Q2Q%5.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.89% on average over the next years. This is quite good.
  • PFMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.22% yearly.
EPS Next Y-39.4%
EPS Next 2Y14.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.54%
Revenue Next 2Y9.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PFMT Yearly Revenue VS EstimatesPFMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
PFMT Yearly EPS VS EstimatesPFMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. PFMT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PFMT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PFMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PFMT Price Earnings VS Forward Price EarningsPFMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

  • PFMT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PFMT is more expensive than 64.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 573.95
PFMT Per share dataPFMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PFMT's earnings are expected to grow with 14.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.89%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PFMT Dividend Analysis

5.1 Amount

  • PFMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PFMT Fundamentals: All Metrics, Ratios and Statistics

PERFORMANT HEALTHCARE INC

NASDAQ:PFMT (12/17/2024, 9:22:18 PM)

After market: 3.56 0 (0%)

3.56

-0.12 (-3.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)N/A
Inst Owners76.31%
Inst Owner Change-89.52%
Ins Owners5.33%
Ins Owner Change0%
Market Cap278.71M
Revenue(TTM)120.78M
Net Income(TTM)-8.14M
Analysts82.22
Price Target7.14 (100.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.76%
Min EPS beat(2)1.96%
Max EPS beat(2)21.57%
EPS beat(4)4
Avg EPS beat(4)85.07%
Min EPS beat(4)1.96%
Max EPS beat(4)292.16%
EPS beat(8)7
Avg EPS beat(8)61.76%
EPS beat(12)10
Avg EPS beat(12)45.51%
EPS beat(16)14
Avg EPS beat(16)55.91%
Revenue beat(2)1
Avg Revenue beat(2)0%
Min Revenue beat(2)-2.19%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)3.71%
Revenue beat(8)4
Avg Revenue beat(8)-0.61%
Revenue beat(12)8
Avg Revenue beat(12)1.53%
Revenue beat(16)9
Avg Revenue beat(16)0.37%
PT rev (1m)0%
PT rev (3m)-8.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-147.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.31
P/FCF N/A
P/OCF 185.19
P/B 3.7
P/tB 10
EV/EBITDA 573.95
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.54%
SpS1.54
BVpS0.96
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.99%
ROE -10.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.17%
ROA(5y)-10.38%
ROE(3y)-9.84%
ROE(5y)-22.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 16.46
Cap/Depr 104.62%
Cap/Sales 5.74%
Interest Coverage N/A
Cash Conversion 309.67%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.67
Altman-Z 6.53
F-Score6
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)75.06%
Cap/Depr(5y)70.94%
Cap/Sales(3y)3.23%
Cap/Sales(5y)3.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-39.4%
EPS Next 2Y14.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.38%
Revenue growth 3Y-9.98%
Revenue growth 5Y-6.09%
Sales Q2Q%5.2%
Revenue Next Year8.54%
Revenue Next 2Y9.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year158.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.02%
OCF growth 3Y-42.97%
OCF growth 5YN/A

PERFORMANT HEALTHCARE INC / PFMT Fundamental Analysis FAQ

What is the fundamental rating for PFMT stock?

ChartMill assigns a fundamental rating of 3 / 10 to PFMT.


Can you provide the valuation status for PERFORMANT HEALTHCARE INC?

ChartMill assigns a valuation rating of 0 / 10 to PERFORMANT HEALTHCARE INC (PFMT). This can be considered as Overvalued.


What is the profitability of PFMT stock?

PERFORMANT HEALTHCARE INC (PFMT) has a profitability rating of 1 / 10.


What is the financial health of PERFORMANT HEALTHCARE INC (PFMT) stock?

The financial health rating of PERFORMANT HEALTHCARE INC (PFMT) is 6 / 10.


What is the earnings growth outlook for PERFORMANT HEALTHCARE INC?

The Earnings per Share (EPS) of PERFORMANT HEALTHCARE INC (PFMT) is expected to decline by -39.4% in the next year.